Tuesday Sep 05, 2023

Season 4: Episode 2 - ICH Guidelines for CMC Development of Biologics/Biosimilars

Episode 2 will detail the various guidelines for biological product development and approval in the market. The reference guidelines discussed in the podcast will include the following:

  • Guidelines that describe the expression construct, cloning, cell bank preparation, and characterization of biological products.
  • Guidelines to be referred for biologics drug substance development and manufacturing.
  • Guidelines to be referred for viral safety evaluation and analytical method validation of the products.
  • Stability management of biological products.


Our Regulatory experts will share more details about the subsidiary guidelines to be referred by a pharma company for streamlining Biologics development.

Comments (0)

To leave or reply to comments, please download free Podbean or

No Comments

Copyright 2022 All rights reserved.

Podcast Powered By Podbean

Version: 20240320